Drawing for DOCTOR TWIN

USPTO serial 76026549

DOCTOR TWIN

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
FLETCHER, TRACY L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DOCTOR TWIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph J. Conklin

JOSEPH J CONKLIN TWIN LABORATORIES INC150 MOTOR PKWYHAUPPAUGE, NY 11788UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Dietary SupplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2001ABN1ABANDONMENT - EXPRESS MAILED—
Aug 7, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 15, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2001NPUBNOTICE OF PUBLICATION—
Sep 19, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance